Comparison of Efficacy and Safety of Cilostazol/Extract of Ginkgo biloba vs. Aspirin in Carotid Atherosclerosis in Patients with Diabetes Mellitus
Diabetes & Metabolism Journal · 2025
DOI: 10.4093/dmj.2025.0146 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Diabetes & Metabolism Journal, 2025. Verfasst von You-Cheol Hwang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Medicine, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine,…. Hauptthemen laut MEDLINE: Aspirin, Ginkgo biloba, Diabetes Mellitus, Type 2, Carotid Artery Diseases. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: SK Chem, Seoul National University Bundang Hospital.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGRUOUND: We conducted a prospective, randomized study to evaluate the combination of cilostazol (CTZ) and extract of Ginkgo biloba (EGb) and compare it with aspirin for the prevention of atherosclerosis progression in patients with type 2 diabetes mellitus (T2DM). METHODS: One hundred five patients with T2DM and increased carotid intima-media thickness (IMT) were randomly assigned to receive either CTZ 200 mg plus EGb 160 mg once daily or aspirin (ASA) 100 mg/day for 12 months. The primary endpoint was the change in maximum carotid IMT. RESULTS: The mean age and body mass index were 61.6±8.4 years and 25.2±3.1 kg/m2 in the CTZ/EGb group and 61.6±7.6 years and 24.5±3.3 kg/m2 in the ASA group, respectively. CTZ/EGb treatment reduced the maximum IMT in the bulb area (from 1.435±0.690 to 1.346±0.688 mm on the right; from 1.359±0.528 to 1.299±0.528 mm on the left), whereas ASA treatment did not, resulting in significant between-group differences (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Medicine, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, Korea.
- Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.
- Physiologic Diagnostic Laboratory, Vascular Laboratory, Seoul National University Bundang Hospital, Seongnam, Korea.
- Department of Internal Medicine, Chosun University Hospital, Chosun University College of Medicine, Gwangju, Korea.
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Förderung
- SK Chem
- Seoul National University Bundang Hospital
Zitieren
APA
Hwang, Y. C., Kim, M. K., Park, J. H., Yun, H. M., Kim, S. Y., & Lim, S. (2025). Comparison of Efficacy and Safety of Cilostazol/Extract of Ginkgo biloba vs. Aspirin in Carotid Atherosclerosis in Patients with Diabetes Mellitus. Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2025.0146
Vancouver
Hwang YC, Kim MK, Park JH, Yun HM, Kim SY, Lim S. Comparison of Efficacy and Safety of Cilostazol/Extract of Ginkgo biloba vs. Aspirin in Carotid Atherosclerosis in Patients with Diabetes Mellitus. Diabetes & Metabolism Journal. 2025. doi:10.4093/dmj.2025.0146
BibTeX
@article{Hwang2025,
author = {Hwang, You-Cheol and Kim, Mi Kyung and Park, Jung Hwan and Yun, Han Mi and Kim, Sang Yong and Lim, Soo},
title = {Comparison of Efficacy and Safety of Cilostazol/Extract of Ginkgo biloba vs. Aspirin in Carotid Atherosclerosis in Patients with Diabetes Mellitus},
journal = {Diabetes & Metabolism Journal},
year = {2025},
doi = {10.4093/dmj.2025.0146}
}
EUVIMED